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Abstract 
Background: A commonly used approach to improve recombinant protein production is to increase the levels of 
expression by providing extra-copies of a heterologous gene. In Komagataella phaffii (Pichia pastoris) this is usually 
accomplished by transforming cells with an expression vector carrying a drug-resistance marker following a screening 
for multicopy clones on plates with increasingly higher concentrations of an antibiotic. Alternatively, defective auxo-
trophic markers can be used for the same purpose. These markers are generally transcriptionally impaired genes lack-
ing most of the promoter region. Among the defective markers commonly used in Saccharomyces cerevisiae is leu2-d, 
an allele of LEU2 which is involved in leucine metabolism. Cells transformed with this marker can recover prototrophy 
when they carry multiple copies of leu2-d in order to compensate the poor transcription from this defective allele.
Results: A K. phaffii strain auxotrophic for leucine (M12) was constructed by disrupting endogenous LEU2. The 
resulting strain was successfully transformed with a vector carrying leu2-d and an EGFP (enhanced green fluorescent 
protein) reporter gene. Vector copy numbers were determined from selected clones which grew to different colony 
sizes on transformation plates. A direct correlation was observed between colony size, number of integrated vectors 
and EGFP production. By using this approach we were able to isolate genetically stable clones bearing as many as 20 
integrated copies of the vector and with no significant effects on cell growth.
Conclusions: In this work we have successfully developed a genetic system based on a defective auxotrophic which 
can be applied to improve heterologous protein production in K. phaffii. The system comprises a K. phaffii leu2 strain 
and an expression vector carrying the defective leu2-d marker which allowed the isolation of multicopy clones after a 
single transformation step. Because a linear correlation was observed between copy number and heterologous pro-
tein production, this system may provide a simple approach to improve recombinant protein productivity in K. phaffii.
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Background
The methylotrophic yeast Komagataella phaffii (formerly 
Pichia pastoris) is one of the most important expression 
platforms for the production of recombinant proteins [1, 
2]. It offers many advantages such as: easy genetic manip-
ulation; growth at high cell densities, e.g. 200 g  L−1 dry 
weight during a glucose-limited fed-batch cultivation 
[3]; ability to produce heterologous proteins at high lev-
els, e.g. more than 18  g  L−1 of lignocellulolytic enzyme 
TrCBH2 [4]; and post-translational modifications similar 
to higher eukaryotes [5].
Due to its biotechnological interest, many studies 
have focused on the genetic improvement of K. phaffii 
in order to optimize protein production. A well-estab-
lished approach to accomplish this is to assure high tran-
scription levels of a heterologous gene thus favoring the 
translation of the desired mRNA. Typically, this can be 
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achieved by constructing expression cassettes under the 
control of strong promoters or/and by screening clones 
bearing multiple copies of the desired gene (for a review 
see [6, 7]). Genetic strategies are available for the isola-
tion of multicopy clones. Yeast cells can be transformed 
with vectors carrying extra copies of the expression cas-
sette cloned in tandem (multimeric construction) [8] or 
successive rounds of transformation can be performed 
using different selection markers [9]. In both cases clon-
ing is labor-intensive and the extent of copy number 
increase is limited [10].
Another option consists in the use of antibiotic-resist-
ance markers, in which case one looks for transformants 
growing in higher concentrations of the antibiotic (direct 
selection method) [11]. A previous study showed that 
this type of selection resulted in the isolation of spo-
radic multicopy integrants with increased productivity 
of the desired protein [12]. Dominant markers can also 
give rise to multicopy clones by posttransformational 
vector amplification (PTVA) [13] or liquid PTVA [14]. It 
has been demonstrated that after transformation with a 
few copies of a vector carrying a drug-resistance marker, 
such as zeocin or G418, cells can be selected in stepwise 
higher concentrations of the drug resulting in the selec-
tion of multicopy clones. The use of PTVA in combina-
tion with the use of rDNA non-transcribed sequence 
(NTS) as an integration target sequence resulted in mul-
ticopy clones in K. phaffii [15]. Besides being a laborious 
and expensive method due to the high costs of eukary-
otic antibiotics, one disadvantage of the use of domi-
nant markers is that a significant number of clones show 
increased natural drug-resistance for other reasons than 
vector copy number.
An alternative strategy is based in the use of defec-
tive auxotrophic markers, i.e. genes that are poorly 
transcribed typically due to extensive deletions of their 
promoters. To compensate the low transcription levels, 
cells need to amplify the copy number of the defective 
marker in order to recover prototrophy. Consequently, 
copy number of the neighboring heterologous gene is 
also amplified [16]. An example of such defective marker 
is the leu2-d allele which contains only 29 base pairs of 
the original promoter and is commonly used in S. cer-
evisiae for plasmid maintenance at high copy number 
under selective pressure [17]. Due to this feature, this sys-
tem has also been used to increase recombinant protein 
production in this yeast [18–20]. This prompted us to 
develop an analogous system to be employed in K. phaf-
fii. To accomplish this, we sought the construction of a 
K. phaffii strain auxotrophic for leucine and the develop-
ment of an integrative expression vector based on leu2-d 
as a tool to increase recombinant protein production in 
this yeast.
Results and discussion
Construction of a leu2 auxotrophic strain
Genetic manipulation of K. phaffii is possible due to its 
widely used transformation system which enables inte-
gration of foreign DNA into the genome via homologous 
recombination [21]. This approach has been successfully 
used to disrupt several genes in order to create auxo-
trophic mutants, e.g. URA5 [22], ARG1, ARG2, ARG3, 
HIS1, HIS2, HIS5 and HIS6 [23]. Recently, a CRISPR-
Cas9 system was developed for K. phaffii which has 
greatly facilitated gene knock out in this yeast [24].
We sought the development of a leucine auxotrophic 
strain by gene knock out of the endogenous K. phaf-
fii LEU2 gene with a leu2::kan disruption cassette. The 
resulting strain (LK) was then transformed with a plas-
mid expressing CreA recombinase for marker removal 
thus generating strain M12 (see Additional file  1 for 
details). Growth analysis on plates containing G418 or 
hygromycin B confirmed the loss of all dominant markers 
(Fig. 1a). The phenotypic behavior of the strains obtained 
with respect to leucine assimilation was then analyzed. 
As expected, LK and M12 strains were not able to grow 
on MD lacking leucine (Fig. 1b). We expected that sup-
plementation of MD medium with leucine would allow 
both leu2 strains to recover prototrophy, however, even 
with an oversuplemmentation (0.08%) of leucine cells 
were unable to grow (Fig. 1b). We reasoned that ammo-
nium sulphate present in MD medium could be affecting 
leucine uptake because when this salt was replaced by 
0.04% leucine as sole nitrogen source both leu2 strains 
grew as well as wild-type X-33 (Fig. 1c). This result is in 
accordance with a previous work [25] which showed that 
cells grown in minimal medium exhibited an increase 
in the rate of leucine uptake when this amino acid was 
the sole nitrogen source. It is known that the addition of 
 NH4+ to yeast cells causes nitrogen catabolite inactiva-
tion and repression of several enzymes and permeases 
involved in the utilization of secondary nitrogen sources 
[26]. Leucine has been shown to be transported by at 
least three systems in S. cerevisiae: GAP (general amino 
acid permease), S1 (high-affinity permease) and S2 (low-
affinity permease) [27]. In  NH4+-containing media the 
activity of GAP is inhibited [28, 29] and the activity of 
S1 and S2 proteins is strongly reduced [30]. In addition, 
two redundant low affinity leucine permeases coded by 
the AGP2 and AGP3 genes are overexpressed when other 
permeases are inhibited [31]. The observation that proto-
trophy could only be achieved in high leucine concentra-
tions can be explained by the fact that, in the presence of 
 NH4+, leucine uptake is mainly due to low-affinity per-
meases. The effects of  NH4+ on leucine permeases could 
be related to intracellular pH as it has been shown that 
a S. cerevisiae leu2 strain was more sensitive to internal 
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acidic conditions [32]. In yeast, amino acids and other 
nutrients are taken up by a proton symport mechanism 
[33]. When  NH4+ (a conjugated weak acid) is internal-
ized by specific transporters it undergoes deprotonation 
and as a result the proton gradient is dissipated leading to 
acidification of the cytosol [34]. To test this, MD medium 
was buffered to pH 6.0 and as a result prototrophy was 
readily recovered as shown in Fig. 1d.
Heterologous expression in K. phaffii M12
In order to test K. phaffii M12 for heterologous expres-
sion we constructed an integrative vector, pGFP-L2, 
containing LEU2 as selectable marker and the enhanced 
GFP (EGFP) reporter gene under the control of the 
methanol-inducible  PAOX1 promoter. After electropo-
ration of K. phaffii M12 with linearized pGFP-L2, one 
colony was randomly chosen and grown under non-
inducible (glycerol) and inducible (methanol) conditions 
to test for intracellular production of the EGFP. Figure 2 
shows the result of fluorescence microscopy analysis 
for the presence of EGFP. As expected, no fluorescence 
was detected under non-inducible conditions and EGFP 
could only be detected when methanol was added. This 
result shows that K. phaffii M12 can recover prototrophy 
upon transformation with a vector carrying a wild-type 
LEU2 marker. However, since the strategy used for LEU2 
disruption in M12 left the promoter region intact, a sin-
gle copy of a defective version of this gene could potently 
integrate at this locus by homologous recombination and 
reestablish prototrophy without the need of other cop-
ies of the marker. In order to develop a system based on 
defective LEU2 for multicopy integration, we decided to 
use the S. cerevisiae leu2-d allele which has 68% identity 
with the K. phaffii LEU2 homologue and should reduce 
the chances of homologous recombination at the dis-
rupted leu2 locus in M12.
Fig. 1 Strain phenotypic analysis. Strains LK and M12 were grown in different media to confirm drug resistance and leucine assimilation. X-33 
was used as a control. a YPD containing G418 or hygromycin B (Hyg B). b MD lacking or not leucine in different concentrations. c MD with leucine 
replacing ammonium sulfate. d Buffered MD (pH 6.0) containing leucine. X-33 wild-type strain with intact LEU2 gene, LK leu2 strain disrupted with 
kan cassette, M12 strain obtained after marker removal with CreA recombinase
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Multiple copy integration
Although the defective leu2-d allele has been successfully 
used to increase plasmid copy number and protein pro-
duction in S. cerevisiae it has not yet been tested for the 
same purpose in K. phaffii. In a previous work, attenu-
ated ADE1 and ADE2 genes involved in adenine biosyn-
thesis were used to develop a color-based system for the 
screening of multicopy integrants in K. phaffii [35]. How-
ever, this system is based on large plasmids and, in some 
cases, the effects of background transcription from vec-
tor sequences were responsible for the recovery of ade-
nine prototrophy.
We constructed an expression vector, pKGFP-ld 
(Fig.  3), carrying the leu2-d defective marker and an 
EGFP reporter construct under the control of the phos-
phoglycerate kinase 1 promoter  (PPGK1). In order to cir-
cumvent the possibility of spurious marker expression, 
leu2-d was cloned in the opposite orientation of the other 
yeast promoters present on the vector  (PPGK1 and  PTEF1). 
Furthermore, the presence of the kan marker under the 
control of dual-promoters allows plasmid selection in 
Escherichia coli and may be used to confirm multicopy 
integration by plating transformed cells on media con-
taining increasing concentrations of the antibiotic G418.
Seven days after transformation of K. phaffii M12 cells 
with pKGFP-ld, colonies of diverse sizes were observed 
on MD plates. Ten transformants representing colo-
nies with different sizes were selected for further analy-
sis. After a few passages on fresh MD plates four clones 
derived from the smallest colonies present on the original 
transformation did not grown upon replica plating and 
were removed from this study. We speculate that these 
abortive clones were transformed with a limited number 
of copies of the defective marker, thus they were unable 
to sustain growth under selective conditions.
A growth kinetic analysis of the six remaining clones 
was performed on MD medium (Fig.  4). The calculated 
maximum growth rates (Table  1) showed that larger 
Fig. 2 Heterologous expression in K. phaffii M12. Intracellular expression of enhanced green fluorescent protein (EGFP) was visualized by epif-
luorescence microscopy. Untransformed (M12) and transformed (M12 + GFP) cells were viewed under differential interference contrast (DIC) or 
fluorescence (FM) microscopy after growth in glycerol or methanol containing media. All images were collected with the same exposure time
Fig. 3 Physical map of pKGFP-ld expression vector for multiple copy 
integration in K. phaffii. leu2-d defective LEU2 allele from S. cerevisiae. 
PPGK1 and PTEF1 promoters from the K. phaffii PGK1 and TEF1 genes, 
respectively, PEM7 synthetic E. coli promoter, kan G418/kanamycin 
resistance gene, EGFP enhanced green fluorescence gene, CYCtt and 
AOX1tt transcription termination sequences from CYC1 and AOX1 
genes, respectively, ori E. coli origin of replication
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clones present on the original transformation plate 
(clones 1, 4, 5 and 6) exhibited a growth profile similar 
to that of K. phaffii X-33 whereas small sized colonies 
(clones 2 and 7), as expected, exhibited smaller growth 
rates. Analysis of variance followed by Tukey’s post-test 
showed significant difference in maximum growth rates 
presented in Table 1 for clones 2 and 7 when compared to 
X-33 (p < 0.05). Similar results were obtained when trun-
cated ADE1 and ADE2 were used as selectable defective 
markers to transform K. phaffii [35]. In this case, multi-
copy clones were also identified as colonies with larger 
sizes. We hypothesized that, in order to compensate the 
poor transcription from leu2-d, cells would require addi-
tional integrated copies of defective marker to recover 
full prototrophy. This prompted us to determine the copy 
number of vectors integrated into the K. phaffii genome 
by Southern blot.
Because pKGFP-ld was linearized with SacI, a restric-
tion site within  PPGK1 (Fig. 3), most events of integration 
would be primarily targeted to this locus. According to 
the schematic representation shown in Fig. 5a, if a single 
copy of the vector had integrated into the PGK1 locus, 
two fragments of 3.4 and 4.8 kb would be expected. Two 
or more integrated copies would yield an additional 
5.5  kb fragment which would increase in intensity for 
each additional copy added. The results from the South-
ern blot analysis are shown in Fig.  5b. As expected, the 
M12 untransformed strain showed the 2.8 kb fragment, 
which corresponds to the intact PGK1 locus. All trans-
formed clones showed the 5.5 kb fragment thus confirm-
ing the in tandem integration of at least two copies of the 
vector. The observation that clone 5 showed other bands 
(including the 2.8 kb fragment) which were not present in 
the other clones suggests that, in this particular clone, the 
vector had integrated in a different manner. This is not 
entirely unexpected since it has recently been shown that 
a transforming cassette can integrate into the K. phaffii 
Fig. 4 Growth kinetic of selected clones transformed with pKGFP-ld. 
Cells were grown on MD medium at 30 °C during 72 h. Growth was 
expressed as the natural logarithm of  OD600 which was measured 
every 30 min. Initial  OD600 = 0.08. X-33 K. phaffii wild-type strain
Table 1 Main features of  the selected clones studied 
in this work
µmax maximum growth rate, ND not determined
Clone µmax  (h




1 0.1596 ± 0.0062 17 19215 ± 2388
2 0.0708 ± 0.0022 7 7705 ± 550
4 0.1614 ± 0.0027 20 23,688 ± 2152
5 0.1408 ± 0.0075 14 18,387 ± 1045
6 0.1650 ± 0.0078 17 20,074 ± 1738
7 0.0502 ± 0.0064 5 6711 ± 206
X-33 0.1707 ± 0.0069 0 ND
Fig. 5 Vector copy number determination. a Schematic representation of genomic contexts and expected sizes of bands obtained after hybridiza-
tion with a PGK probe (annealing positions are represented by a red line). Dark grey areas correspond to integrated  PPGK1 sequences derived from 
vector. b Result of Southern blot analysis. c Correlation between copy number and maximum growth rates of selected clones. Error bars represent 
standard error of the mean. M O’GeneRuler 1 kb DNA ladder, M12 K. phaffii leu2 strain, E EcoRI restriction site
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genome in different cassette-to-cassette orientations 
and secondary recombination events may also occur 
[36]. Also, we cannot exclude the possibility of off-target 
integration events mediated by non-homologous end 
joining (NHEJ) which is the main repair system in fila-
mentous fungi and higher eukaryotes [37]. Table 1 shows 
that that faster growing clones 1, 4, 5 and 6 showed the 
highest vector copy number (≥14 copies) as compared 
to slower growing clones 2 and 7 which had no more 
than 7 copies. Growth rate and copy number showed a 
linear correlation  (R2  =  0.8748) (Fig.  5c). These results 
are in agreement with the prediction that faster growing 
clones would have more integrated copies of the defec-
tive marker.
Genetic stability
Previous works have shown that single or low copy inte-
grated messages are genetically stable in K. phaffii under 
different conditions [38, 39], however, few studies have 
focused on the integrity of multicopy clones. Since mul-
ticopy K. phaffii strains generally arise from multiple 
events of homologous recombination at the same locus, 
the integrated messages are typically repeated in tandem. 
The stability of such array may be compromised by exci-
sional recombination which can “loop out” the genetic 
message under non-selective conditions [14], [40]. In 
order to test the stability of integrated pKGFP-ld, trans-
formed cells were grown in non-selective medium (YPD) 
for 36 and 72 generations. The culture was transferred 
to fresh medium every 24 h to ensure that cells were in 
exponential phase throughout the experiment. After 
growth for 96 h or 144 h (36 and 72 generations, respec-
tively), copy number of the selected clones was assessed 
by Southern blot analysis which showed that all clones 
maintained the original vector copy number (data not 
shown).
In a recent work, S. cerevisiae strains with multiple 
integrated cassettes bearing different defective auxo-
trophic markers also showed mitotic stability under pro-
longed nonselective conditions [41]. S. cerevisiae cells 
transformed with five or more copies of an integration 
vector conferring resistance to G418 and expressing 
SUC2 (invertase) were very unstable during long-term 
culture in non-selective medium [42]. Likewise, when K. 
phaffii was transformed with a set of vectors containing 
sequentially increasing copies of porcine insulin precur-
sor gene (PIP), both low and high copy strains were stable 
in serial culture in non-selective YPD medium. However, 
in high copy strains, loss of PIP cassettes was observed 
after 96 h of methanol induction [43].
Based on these previous results, it has been proposed 
that multicopy strains should be carefully evaluated 
for genetic stability especially under conditions of high 
expression or secretion [43]. In our work, since EGFP 
was produced intracellularly from a moderately strong K. 
phaffii promoter  (PPGK1) [44], it is possible that the titers 
of this particular protein were not high enough to com-
promised cell growth as shown on Fig. 4, hence, genetic 
stability was observed.
Correlation between copy number and protein production
In order to determine the correlation between plas-
mid copy number and increased heterologous protein 
production, intracellular fluorescence emission of each 
selected clone was determined by flow cytometry. As 
shown in Fig.  6a, all selected clones exhibited fluores-
cence emission higher than the untransformed M12 
strain. EGFP production was the highest in clones 1, 4, 
5 and 6 which exhibited higher plasmid copy number, 
whereas moderate production was observed in clones 2 
and 7 (Table 1). Analysis of variance followed by Tukey´s 
post-test showed significant difference in EGFP produc-
tion in clones 1, 4, 5 and 6 when compared to M12 con-
trol strain (p < 0.05). The EGFP fluorescence from clones 
2 and 7 was not high enough to result in statistically sig-
nificant differences in EGFP production in comparison to 
M12 (p  >  0.05). However, it is important to notice that 
the percentage of M12 cells producing EGFP (cells posi-
tive for EGFP) was less than 1%. As shown in Fig. 6b, we 
observed a linear correlation between vector copy num-
ber and EGFP production as measured by flow cytometry 
 (R2 = 0.8757). It is expected that at a certain copy num-
ber the production of the heterologous protein might 
become detrimental to the cell; however, for the exam-
ined clones, we did not observe a decrease in cell viability 
nor in EGFP production which augmented linearly with 
up to 20 integrated copies. Similarly, an increase of up to 
eight copies of the hepatitis B surface antigen (HBsAg) 
gene showed a linear correlation with the concentration 
of mRNA and translated protein in K. phaffii [45].
However, the relationship between gene copy num-
ber and protein production is not always linear and in 
some cases it proved to be detrimental, especially for 
secreted proteins [6]. In another study involving EGFP, 
an increase of the secreted protein was observed with 
up to three copies but a decrease occurred with six cop-
ies [46]. When multicopy clones were used to produce 
intracellular human superoxide dismutase (hSOD) and 
secreted human serum albumin (HSA) a difference was 
observed in the correlation of gene copy number and 
productivity between non-secreted and secreted proteins 
[15]. The productivity of hSOD correlated linearly with 
gene copy number, while HSA productivity increased up 
to approximately 5–7 gene copies, and then decreased 
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with higher copy numbers. K. phaffii strains secreting 
human trypsinogen under the control of the AOX1 pro-
moter presented a positive correlation between copy 
number and product yield from 1 to 2 copies per cell, 
and a negative correlation at 3 or more copies [47]. Upon 
overexpression, great part of the heterologous protein 
was retained in the insoluble fraction of the endoplasmic 
reticulum. From this studies it is clear that bottlenecks in 
the secretory pathway are to some extent responsible for 
the low productivity of some multicopy clones [6].
Since the effect of gene dosage may vary from one pro-
tein to another, it is not possible to define the optimal 
copy number for any specific heterologous gene which 
should be assessed on a case-by-case basis. However, by 
using the approach presented in this work one can easily 
obtain a panel of clones with different copy numbers to 
be screened for the desired application. Furthermore, we 
envision that this approach might be also applied in syn-
thetic biology studies in which different doses of specific 
genes may be required. This could be rapidly achieved by 
transforming M12 with different plasmids bearing the 
leu2-d marker following a screening for the desired phe-
notype. Work is underway in our laboratory to test this 
new application.
Conclusions
In this work, we proposed a simple approach to obtain 
K. phaffii clones containing multiple copies of a desired 
expression vector. Our genetic system is based on a K. 
phaffii strain auxotrophic for leucine which is trans-
formed with an expression vector bearing a defective 
leu2-d marker. The main advantage of the approach pro-
posed here is the ease in selecting multicopy clones, in 
our case this was based on colony size. This approach 
might serve as a first step in the construction of strains 
with higher productivity thus lowering the costs of indus-
trial recombinant protein production.
Methods
Strains and growth conditions
Komagataella phaffii GS115 (his4) and X-33 (Invitrogen) 
were used as a source of template DNA to amplify LEU2 
and cell host to perform transformation with the disrup-
tion cassette, respectively. K. phaffii was routinely grown 
on YPD (1% yeast extract, 2% peptone and 2% glucose) 
at 28  °C. Solid medium was prepared by the addition of 
2% agar. After transformation yeast cells were plated on 
YPD containing 300–500 µg mL−1 G418 or 150 µg mL−1 
hygromycin B. Transformants were tested on MD [0.34% 
Yeast Nitrogen Base (YNB), 1% ammonium sulphate, 
2% glucose, 0.4  µg  mL−1 biotin and 2% agar] and buff-
ered MD [MD with 100  mM potassium phosphate (pH 
6.0)] supplemented or not with 0.04 or 0.08% leucine. 
For induction of heterologous gene expression from the 
 PAOX1 promoter cells were grown in a medium contain-
ing 1% yeast extract, 2% peptone, 100  mM potassium 
phosphate (pH 6.0), 0.34% YNB, 1% ammonium sulphate, 
0.4  µg  mL−1 biotin supplied with 1% glycerol (BMGY 
medium) or 0.5% methanol (BMMY medium). When liq-
uid medium was used, growth was carried out under agi-
tation (200 rpm) in shake flasks with a volume at least 10 
times greater than the volume of the medium.
Cloning procedures were carried out in E. coli XL10-
gold (Stratagene, USA) which was cultivated in modi-
fied LB medium (0.5% yeast extract, 1% peptone and 1% 
NaCl) containing the appropriate antibiotic for selection 
of transformants (100 µg mL−1 ampicillin or 50 µg mL−1 
kanamycin). Bacterial cells were grown at 37 °C with con-
stant shaking (250 rpm). For solid medium, 1.5% agar was 
added.
Fig. 6 Intracellular EGFP production. a Flow cytometry analysis of the cells positive for EGFP production. b Correlation between copy number and 
EGFP production. M12 leu2 strain. Error bars represent standard error of the mean. Asterisks indicate significant difference between the evaluated 
clone and the M12 control strain according to ANOVA followed by Tukey’s post-test (p < 0.05)
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PCR
Phusion high-fidelity DNA polymerase (Finnzymes) was 
routinely used for PCR according to the instructions of 
the manufacturer. To amplify LEU2, Easy Taq DNA poly-
merase (LGC Bio, Brazil) was used in a final volume of 
50 μL consisting of 0.2 mM dNTP, 0.2 μM each primer, 
2  mM  MgCl2, Easy Taq buffer 1X, 2 U polymerase and 
1–5  ng template DNA. PCR involved an initial dena-
turation step at 96 °C for 3 min followed by 30 cycles of 
60 s/94 °C, 1 min/60 °C, 2 min/72 °C and a final elonga-
tion step at 72 °C for 5 min.
DNA manipulations
Plasmid extraction, electrophoretic analysis and other 
basic DNA manipulations were performed as described 
previously [48]. For DNA elution from agarose gels and 
for amplicon purification Wizard SV Gel and PCR Clean-
Up System (Promega, USA) were used according to the 
manufacturer’s instructions, respectively. Genomic DNA 
was purified by using Wizard Genomic DNA Purification 
Kit (Promega, USA) using the manufacturer’s protocol.
Construction of disruption cassette
First, LEU2 was amplified by PCR from K. phaffii GS115 
genome with primers PpLEU2-F1 and PpLEU2-R2 
(Table 2) which introduce PvuII restriction sites at their 
5´-ends. Primers were designed based on the published 
sequence of the K. phaffii chromosome 3 (accession # 
FR839630.1). The amplified 1.7 kb fragment included the 
LEU2 coding region and ~300 bp of both upstream and 
downstream sequences. LEU2 was cloned into pGEM-
T easy (Promega) resulting in pGEM-LEU. This vector 
was digested with EcoRV to remove 375  bp of the cod-
ing region of LEU2 (positions 405–750). To disrupt 
LEU2, first, a 1.7  kb fragment containing a kan expres-
sion cassette flanked by loxP sites was amplified from 
pPICKα [49] with primers ZeoBlas-F3 and ZeoBlas-R3 
(Table 2). This amplicon was cloned into EcoRV-digested 
pGEM-LEU generating plasmid pLEUΔkan. Finally, the 
leu2::kan disruption cassette was released after digestion 
of pLEUΔkan with PvuII prior to yeast transformation.
Marker excision
A vector based on pYRCre was constructed in order to 
promote marker excision in K. phaffii. Plasmid pYRCre 
was originally used to express the CreA recombinase in S. 
cerevisiae [49]. The  PGAL1 promoter present in this vector 
was removed after XbaI digestion and replaced by a 441-
bp fragment corresponding to the S. cerevisiae  PTEF1 pro-
moter which was obtained by PCR using primers TEF-1F 
and TEF-1R (Table  2). The amplicon was digested with 
AvrII and cloned into XbaI-digested pYRCre. The result-
ing vector, pYRCre2, was used to transform K. phaffii and 
selection was made on YPD plates containing hygromy-
cin B. Transformants were incubated at 28 °C for 3 days 
to allow expression of CreA recombinase and then 
selected clones were transferred to an YPD plate for plas-
mid curing. Isolated colonies were replica plated on YPD 
plates containing G418 or hygromycin B to confirm the 
removal of kan marker and cure of pYRCre2, respectively.
Construction of expression plasmid pGFP‑L2
First, a vector constructed in our lab derived from pPIC9 
(Invitrogen, USA) with the EGFP reporter gene under 
the control of the  PAOX1 promoter was digested with 
EcoRV. This digestion removed the entire HIS4 sequence, 
which was replaced by the LEU2 gene obtained from 
pGEM-LEU after digestion with PvuII. The resulting vec-
tor, pPIC-LEU, was digested with BamHI and NotI to 
remove the EGFP gene which was fused in-frame to the 
α-factor secretion signal. This secretable version of EGFP 
was replaced by a 741 bp EGFP fragment from pEGFP-
N3 (Clontech, USA) after digestion of this plasmid with 
the same enzymes. The resulting plasmid, which allows 
Table 2 Primers used in this work
* Restriction sites are underlined





ZeoBlas-F3 CGGATCCATAACTTCGTATAATGTATGCTATACGAAGTTATAGATCTCCCACACACCATAGCTTCAAAATG BamHI and BglII
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intracellular expression of EGFP, was named pGFP-L2. 
Before K. phaffii transformation pGFP-L2 was linearized 
with SacI to promote targeted integration to the  PAOX1 
locus.
Construction of expression vector pKGFP‑ld
The leu2-d allele was amplified by PCR from S. cerevisiae 
genome with primers 5- and 3-leud (Table 2). The ampli-
fied 1.4  kb fragment included the LEU2 coding region 
with its transcription termination region and only 29 bp 
of its promoter [17]. The leu2-d amplicon was cloned 
into pBlueScript SK II (Agilent Technologies) and then 
liberated after BglII digestion for subcloning into BamHI-
linearized pPICK2 [50] resulting in pK-ld vector. This 
vector was digested with SacI and NotI to remove the 
α-factor secretory sequence. This digestion also removed 
a 179 bp fragment from  PPGK1 which was restored when 
the EGFP gene was cloned. The 916 bp fragment includ-
ing the EGFP gene fused to the 179 bp fragment from the 
 PPGK1 was obtained by digestion of pPICK-GFP [a vector 
derived from pPIC9 (Invitrogen) for intracellular expres-
sion of EGFP under the control of  PPGK1] with SacI and 
NotI. Cloning of this 916 bp fragment into pK-ld resulted 
in pKGFP-ld vector. This vector was linearized with SacI 
to target integration to the PGK1 locus.
Yeast transformation
Komagataella phaffii X-33 was transformed by elec-
troporation following the protocol described in the 
Pichia Expression Kit (Invitrogen). Transformation with 
pYRCre2 was carried out as previously described for the 
auto-replicative pPICHOLI vector [51].
Fluorescence microscopy
Komagataella phaffii cells expressing EGFP were grown 
in 5 mL BMGY for 16 h at 28 °C. After cell count, pelleted 
cells were re-suspended in 20 mL BMMY to a final  OD600 
of 0.3. The culture was incubated at 28 °C and methanol 
was added to a final concentration of 0.5%. After 24  h 
of induction cells were imaged in a Zeiss Axio Observer 
Z1 Inverted Fluorescence Microscope equipped with 
63× NA 1.4 oil immersion objective and a cooled CCD 
camera to analyze EGFP fluorescence. The images were 
acquired with Zen2011 software (Zeiss) and manipu-
lated with Microsoft Office Picture Manager or Adobe 
Photoshop.
Growth kinetics
A fresh colony was inoculated in 500 µL of MD medium 
in a deep-well plate and incubated for 24 h at 30 °C and 
200  rpm. The appropriate volume of this culture was 
inoculated in 100 µL of MD to an  OD600  =  0.08 in a 
96-well plate. Cell growth was performed on the Epoch 
Microplate Spectrophotometer (Biotek) by incubating at 
30 °C under agitation of 300 rpm for 72 h.  OD600 data was 
collected every 30  min. Three biological replicates were 
tested for each analyzed clone and the mean of the three 
values was presented. Natural logarithm of  OD600 values 
was used to construct growth curves. Maximal growth 
rate was calculated from the slope of the linear section of 
these curves (up to eight hours growth).
Southern blot analysis
Yeast cells were grown in 40 mL of MD medium at 30 °C 
under agitation during 24 h and the DNA was extracted 
using phenol–chloroform as previously described [48]. 
Aproximately 10 µg of genomic DNA were digested with 
EcoRI at 37  °C overnight. Digested DNA was applied in 
0.8% agarose gel and then transferred to nitrocellulose 
membrane as described [48]. Probe labeling, hybridiza-
tion and detection were made using the AlkPhos Direct 
Labeling and CDP-Star Detection System (GE Life Sci-
ences) following especifications of the manufacturer. The 
probe used was a fragment of ~600 bp corresponding to 
the PGK1 promoter obtained by digestion of pKGFP-ld 
with BglII and BamHI. The temperature for hybridiza-
tion was 55  °C. Chemiluminescence was detected using 
the Amersham Imager 600 system (GE Life Sciences) and 
band intensity was measured with the use of the Image-
Quant TL 8.1 software.
Genetic stability testing
The stability of the heterologous DNA integrated into 
the yeast genome was tested in shake flasks after 36 and 
72 generations. A fresh colony was grown in 10 mL YPD 
medium for 24 h at 30 °C and 200 rpm. Then, 400 µL of 
this pre-inoculum were inoculated in 40  mL YPD and 
incubated under the same conditions for 24 h. A 400 µL 
sample of the culture was transferred to a new flask with 
40 mL YPD and incubated under the same conditions for 
24 h. This procedure was repeated four more times for a 
total growth time of 144  h. After 96  h (36 generations) 
and 144 h (72 generations) genomic DNA was extracted 
and submitted to Southern blot analysis as described 
above.
Flow cytometry
Yeast cells were grown in 5 mL of MD medium for 24 h at 
30 °C and agitation. The required volume of each pre-inoc-
ulum was inoculated in 5 mL of MD to start the culture 
with an OD of 0.5. After 24 h of incubation at 30 °C under 
agitation cells were washed twice with PBS (137 mM NaCl, 
2.7  mM KCl, 10  mM  Na2HPO4 and 2  mM  KH2PO4, pH 
7.4) containing 0.5% Tween by centrifugation at 3000×g 
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for 5 min at 4 °C. Cells were suspended in the required vol-
ume of PBS to obtain approximately  106 cells  mL−1. Cells 
were maintained at 4  °C until analysis with FACSVerse 
flow cytometer. All samples were collected with identical 
voltage parameters. Acquired data were analyzed using 
the FlowJo software. The gating strategy included: (a) gat-
ing on yeast cells on forward versus side scatter plots; (b) 
gating on single cells using forward scatter width versus 
forward scatter height plots and (c) selecting positive cells 
based on histograms from wild-type cells. Three biologi-
cal replicates were tested for each analyzed clone and the 
mean of the three values is presented.
Data analysis
Statistical analyses and figures were made on GraphPad 
Prims 5 software. ANOVA followed by Tukey’s post-test 
was applied. Error bars on graphics represent standard 
error of the mean.
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